NewsSource: EClinCloud

Event Preview | Join EClinCloud at the 5th Patient-Centric Digital Innovation Annual Conference

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud.

Article image

Recently, the release and implementation of a series of policies across the pharmaceutical industry have accelerated a return to medical fundamentals among companies: during R&D, focusing steadily on developing effective, innovative drugs that benefit patients and address unmet clinical needs; and during the clinical stage, ensuring the scientific, rational, standardized, and proper use of medications so that patient benefit is realized in practice. "A New Ecosystem of Compliant Transformation, Winning the Future Through Innovative Models" will be the defining theme going forward.

From September 21–22, the 5th Patient-Centric Digital Innovation Annual Conference, themed "A New Ecosystem of Compliant Transformation, Winning the Future Through Innovative Models," will be held at Crowne Plaza Beijing Sun Palace.

As a promoter of digital clinical trials in China, EClinCloud has been invited to attend this conference. Zhang Zhiwei, Director of Medical Operations at EClinCloud, will give a presentation titled "Electronic Clinical Reported Outcomes: Enabling DCT Implementation and Accelerating Pharmaceutical Innovation" on how eCOA supports drug R&D under new models.

Driven by science and medicine, EClinCloud has built an end-to-end, interconnected, integrated cloud platform for digital clinical trials and provides clinical trial endpoint assessment solutions across therapeutic areas, including the central nervous system (CNS) and ophthalmology. In addition to an extensive scale library, we have an experienced team of experts providing one-stop scale services to help clients address scale-related challenges in clinical trials faster and more effectively.

Presentation Details

Time: September 21, 2023, 10:55–11:20

Location: Crowne Plaza Beijing Sun Palace

Topic: Electronic Clinical Reported Outcomes: Enabling DCT Implementation and Accelerating Pharmaceutical Innovation



Article image

Zhang Zhiwei

Director of Medical Operations, EClinCloud

  • Over 14 years of experience in clinical operations;
  • Previously held clinical operations roles at companies including Pfizer, Covance, and Novo Nordisk;
  • Participated in multiple international and domestic multicenter trials covering project management, people management, and other responsibilities across therapeutic areas including oncology, autoimmune diseases, diabetes, and hemophilia;
  • Also has experience in international regulatory affairs and clinical trial IT platforms.

Article image

Scan the QR code to view the full conference agenda

Article image



About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interconnected, end-to-end cloud platform for clinical trials (including technology products and offerings such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, along with solutions such as scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including the central nervous system and ophthalmology). By combining cutting-edge technology with life sciences data, EClinCloud is building a globally leading, patient-centric SaaS cloud platform for clinical evidence support to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



Article image


Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.